Homozygosity of KIR2DL3 and HLA-C1 alleles has been reported to lead to lower levels of NK inhibition than other pairs of KIR ligand combinations [75,76], suggesting that this underlies the enhanced response to hepatitis C. This evidence concerns the gene KIR2DL3 and hepatitis C virus infection.